Trade Bristol Myers ^BMY

Vontobel Holding Ltd. Sells 46,675 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Vontobel Holding Ltd. Lowers Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages

Is Bristol Myers Squibb (BMY) Still Undervalued After Its Recent Share Price Rebound?

Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact

Four quiet Q4 winners and what the stocks must do to keep rolling in 2026

U.S. Capital Wealth Advisors LLC Sells 47,717 Shares of Bristol Myers Squibb Company $BMY

Coho Partners Ltd. Has $2.18 Million Stock Holdings in Bristol Myers Squibb Company $BMY

True North Advisors LLC Takes Position in Bristol Myers Squibb Company $BMY - Stock Observer

Trust Co. of Vermont Has $2.55 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Exchange Traded Concepts LLC Purchases 83,214 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by First Bank & Trust

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

FDA Approves Bristol-Myers Squibb's Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma

BofA Upgrades Bristol-Myers Squibb (BMY) Stock to Buy from Neutral

Bristol Myers Squibb Company $BMY Shares Sold by Wedge Capital Management L L P NC

Bristol Myers Squibb Company $BMY Shares Sold by Voya Investment Management LLC - Stock Observer

Great week for Bristol-Myers Squibb Company (NYSE:BMY) institutional investors after losing 0.8% over the previous year

Bristol Myers Squibb Company $BMY Shares Sold by Contravisory Investment Management Inc.

10 Best Stocks to Invest in for the Next 3 Years

HBM Holdings (SEHK:2142): Valuation Check After Bristol Myers Squibb Collaboration Validates Growth Prospects

Drug companies line up to make deals with Trump after initial hesitation

Trump unveils major drug price deals with 9 Pharma giants, launches TrumpRx.gov to cut medicine costs in US

Trump announces lower drug price deals with 9 pharmaceutical companies

TrumpRx latest news today: TrumpRx explained: How Trump's new drug price deals with 9 pharma companies could save patients money - The Economic Times

Eliquis® (apixaban), the Nation's #1 Prescribed Oral Blood T

10 Best Stocks to Buy for the Next 5 Years

Rep. Julie Johnson Sells Off Shares of Bristol Myers Squibb Company (NYSE:BMY) - Markets Daily

Trump to announce new deals with major drugmakers to lower US prescription drug prices

I'll Play, Says Jim Cramer About Bristol-Myers (BMY)

Zacks Research Has Pessimistic Outlook of BMY Q3 Earnings - Markets Daily

Montecito Bank & Trust Invests $567,000 in Bristol Myers Squibb Company $BMY

Several top drugmakers to lower US prices for some drugs-sources

Medicare enrollees to pay 50% less for some drugs in 2025, report says - Yahoo News Canada

Bristol Myers Squibb (NYSE:BMY) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.

Czech National Bank Acquires 19,513 Shares of Bristol Myers Squibb Company $BMY

Corient Private Wealth LLC Sells 22,382 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb and Accenture Unveil Mosaic: Mumbai's First AI-Powered Content Hub, ETPharma

Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets

Bristol Myers Squibb (NYSE:BMY) Upgraded at Bank of America - Daily Political

Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review

Accenture helps Bristol Myers Squibb to launch AI-based medical content hub Mosaic - The Times of India

Bristol Myers Squibb Company $BMY Shares Sold by Valeo Financial Advisors LLC

Texas Permanent School Fund Corp Lowers Stake in Bristol Myers Squibb Company $BMY

Osaic Holdings Inc. Increases Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb launches AI-led content hub 'Mosaic' with Accenture as part of $130 mn investment

Harbour Biomed closes busy year with $1B+ BMS deal | BioWorld

Is Bristol Myers (BMY) Undervalued After Its Recent Share Price Rebound?

Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies

Harbour BioMed, Bristol Myers More Than $1.1 Bln Deal For Next-Gen Multi-Specific Antibodies

Building a Healthier Future Together: Strengthening Cancer Care Across Africa Through Partnership

Top Pharmaceutical Stocks To Consider - December 16th

Shorepoint Capital Partners LLC Takes Position in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb named industry company of the year at Pharma Industry Awards 2025

Assessing Bristol Myers Squibb After 16% Rally and New Drug Approvals in 2025

Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry

Best Dividend Stocks To Follow Today - December 15th - Markets Daily

Bristol Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Bank of America

Bristol Myers Squibb (NYSE:BMY) Stock Unloaded Rep. Julie Johnson

Pitcairn Co. Trims Position in Bristol Myers Squibb Company $BMY - Markets Daily

National Bank of Canada FI Acquires 860,464 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Purchased by Cullen Capital Management LLC

National Bank of Canada FI Has $95.80 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Pitcairn Co. Trims Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Marex Group plc Takes Position in Bristol Myers Squibb Company $BMY - Daily Political

From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer

Bristol Myers Squibb Company $BMY Shares Purchased by AQR Capital Management LLC

Bristol Myers Squibb Company $BMY is Birchview Capital LP's Largest Position - Stock Observer

Bristol Myers Squibb Company $BMY Shares Bought by Bellevue Group AG - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Price Target Raised to $55.00 - Stock Observer

Bcwm LLC Boosts Stake in Bristol Myers Squibb Company $BMY - Daily Political

Dividend Stocks To Follow Now - December 12th - Markets Daily

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Lowers Holdings in Bristol Myers Squibb Company $BMY

Peapack Gladstone Financial Corp Reduces Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer

Australia & NZ CTCL Market to Reach USD 359.10M by 2035

Bristol Myers Squibb Company (NYSE:BMY) Raises Dividend to $0.63 Per Share - Markets Daily

Bristol Myers Squibb Company (NYSE:BMY) Plans Dividend Increase - $0.63 Per Share

Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications

Bristol-Myers Squibb (BMY) Receives a Hold from Wells Fargo | Markets Insider

Wells Fargo & Company Forecasts Strong Price Appreciation for Bristol Myers Squibb (NYSE:BMY) Stock - Markets Daily

Jefferies Remains Bullish on Bristol-Myers Squibb Company (BMY)

Did New Gotistobart Data Just Shift BioNTech's (BNTX) Oncology-Led Diversification Narrative? - Simply Wall St News

Daiwa Securities Group Inc. Raises Stock Holdings in Bristol Myers Squibb Company $BMY

Bank of Nova Scotia Buys 183,478 Shares of Bristol Myers Squibb Company $BMY

China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer | South China Morning Post

Taking Stock of Bristol-Myers Squibb (BMY): Exploring Valuation After Recent Share Price Momentum

Somatic evolution following cancer treatment in normal tissue

Non-Hodgkin Lymphoma Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb

Myelofibrosis Market to Expand Significantly by 2034, States DelveInsight Report | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros Therapeutics

Bristol Myers Squibb Company $BMY Shares Bought by Investment Management Corp of Ontario

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Week ahead: Fed to hike 100bps into a recession?

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk